| 11/04/2026 9:00 AM | Seres Therapeutics (1609809) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2026 6:05 AM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/26/2026 3:30 PM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/23/2026 11:15 PM | Seres Therapeutics (1609809) Filer | Form EFFECT | |
| 08/18/2026 4:22 PM | DesRosier Thomas (1435744) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 4:25 PM | Henn Matthew R (1767321) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 4:27 PM | Seres Therapeutics (1609809) Issuer Shaff Eric D. (1643734) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 4:33 PM | Brady Kelly (2117686) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2026 3:31 PM | Seres Therapeutics (1609809) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 08/05/2026 9:30 AM | Seres Therapeutics (1609809) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2026 6:05 AM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MCRB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/04/2026 3:03 PM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/10/2026 3:15 PM | DesRosier Thomas (1435744) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Brady Kelly (2117686) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Berenson Stephen (1760671) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Rosiello Robert L. (1645041) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Seres Therapeutics (1609809) Issuer Shaff Eric D. (1643734) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Ausiello Dennis A (1381994) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Dere Willard H (1311569) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Fraser Claire (1382031) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Seres Therapeutics (1609809) Issuer Thorell Marella (1826323) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Henn Matthew R (1767321) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Kender Richard N (1381205) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:15 PM | Graves Kurt (1406337) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 3:05 PM | Seres Therapeutics (1609809) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 07/08/2026 3:05 PM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/08/2026 7:00 AM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/02/2026 5:09 PM | Rosiello Robert L. (1645041) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 5:12 PM | Berenson Stephen (1760671) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 5:05 PM | Ausiello Dennis A (1381994) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 6:05 AM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/01/2026 3:30 PM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/19/2026 3:05 PM | Henn Matthew R (1767321) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:05 PM | Brady Kelly (2117686) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:05 PM | DesRosier Thomas (1435744) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:05 PM | Seres Therapeutics (1609809) Issuer Shaff Eric D. (1643734) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 9:30 AM | Seres Therapeutics (1609809) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/05/2026 6:05 AM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/27/2026 3:05 PM | Seres Therapeutics (1609809) Filer | Form DEF 14A | |
| 03/12/2026 9:00 AM | Seres Therapeutics (1609809) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/12/2026 6:05 AM | Seres Therapeutics (1609809) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Chase, Wells Fargo and Capital One all showed errors on Nov. 16 (Ad) On November 16, customers of Chase, Bank of America, Wells Fargo, Capital One and Zelle reported errors when trying to reach their money. The outage lasted hours.
Cedar Gold Group points out that physical gold has no login, no server and needs no one's permission. Its free Wealth Protection Playbook shows how to keep part of your savings outside the banking system. Get Cedar Gold Group's free Wealth Protection Playbook and see your options today. |
| 03/11/2026 5:30 PM | Brady Kelly (2117686) Reporting Seres Therapeutics (1609809) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/11/2026 5:39 PM | Brady Kelly (2117686) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:33 PM | Seres Therapeutics (1609809) Issuer Thorell Marella (1826323) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:35 PM | Henn Matthew R (1767321) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:36 PM | Kender Richard N (1381205) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:31 PM | DesRosier Thomas (1435744) Reporting Seres Therapeutics (1609809) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |